Journal Mobile Options
Table of Contents
Vol. 34, No. 3, 2001
Issue release date: March 2001

Spina Bifida Outcome: A 25-Year Prospective

Bowman R.M. · McLone D.G. · Grant J.A. · Tomita T. · Ito J.A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Open spina bifida is the most complex congenital abnormality compatible with long-term survival. This report outlines the 20- to 25-year outcome for our original cohort of patients with a myelomeningocele treated in a nonselective, prospective manner. Methods: Of the initial 118 children, 71 patients were available for our most recent review. Nineteen patients have been lost to follow-up and 28 patients have died. Data were collected on: motor level, shunt status, education/employment, seizure history, mobility, bladder/bowel continence, tethered cord, scoliosis, latex allergy, posterior cervical decompression, tracheostomy and/or gastrostomy tube. Results: Mortality (24%) continues to climb into young adulthood. Eighty-six percent of the cohort have cerebrospinal fluid diversion, with 95% having undergone at least one shunt revision. Thirty-two percent have undergone a tethered cord release, with 97% having an improvement or stabilization in their preoperative symptoms. Forty-nine percent have scoliosis, with 43% eventually requiring a spinal fusion. Sixteen patients (23%) have had at least one seizure. Eighty-five percent are attending or have graduated from high school and/or college. More than 80% of young adults have social bladder continence. Approximately 1/3 of patients are allergic to latex, with 6 patients having experienced a life-threatening reaction. Conclusion: At least 75% of children born with a myelomeningocele can be expected to reach their early adult years. Late deterioration is common. One of the greatest challenges in medicine today is establishing a network of care for these adults with spina bifida.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. McLone DG: Care of the neonate with a myelomeningocele. Neurosurg Clin North Am 1998;9:111–120.
  2. McLone DG: Results of treatment of children born with a myelomeningocele. Clin Neurosurg 1983;30:407–412.
  3. McLone DG: Spina bifida today: Problems adults face. Semin Neurol 1989;9:169–175.

    External Resources

  4. McLone DG: Continuing concepts in the management of spina bifida. Pediatr Neurosurg 1992;8:254–256.
  5. McLone DG, Dias L, Kaplan WE, Sommers MW: Concepts in the management of spina bifida. Concepts Pediatr Neurosurg 1985;5:97–106.
  6. Hunt GM: Open spina bifida: Outcome for a complete cohort treated unselectively and followed into adulthood. Dev Med Child Neurol 1990;32:108–118.
  7. Hunt GM, Poulton A: Open spina bifida: A complete cohort reviewed 25 years after closure. Dev Med Child Neurol 1995;32:108–118.
  8. Hunt GM, Palmer C: The median survival time in open spina bifida. Dev Med Child Neurol 1997;39:568.
  9. Hunt GM: Non-selective intervention in newborn babies with open spina bifida: The outcome 30 years on for the complete cohort. Eur J Pediatr Surg 1999;9:5–8.

    External Resources

  10. Asher M, Olson J: Factors affecting the ambulatory status of patients with spina bifida cystica. J Bone Joint Surg [A] 1983;65:350–356.
  11. McDonald CM, James CC, Moska VS, Shurtleff DB: Ambulatory outcome of children with myelomeningocele: Effect of lower-extremity muscle strength. Dev Med Child Neurol 1991;33:482–490.
  12. Dias ML, McLone DG: Hydrocephalus in the child with dysraphism. Neurosurg Clin North Am 1993;4:715–726.
  13. La Marca F, Herman M, Grant JA, McLone DG: Presentation and management of hydromyelia in children with Chiari type-II malformation. Pediatr Neurosurg 1997;26:57–67.
  14. McLone DG, Herman JM, Gabrieli AP, Dias L: Tethered cord as a cause of scoliosis in children with a myelomeningocele. Pediatr Neurosurg 1990;16:8–13.
  15. Reigel DH: Tethered spinal cord. Concepts Pediatr Neurosurg 1983;4:142–164.
  16. Venes JL, Stevens EA: Surgical pathology in tethered cord secondary to myelomeningocele repair: Implications for initial closure technique. Concepts Pediatr Neurosurg 1983;4:165–185.
  17. Piggott H: The natural history of scoliosis in myelodysplasia. J Bone Joint Surg [B] 1980;62:54–58.
  18. Kelly KJ, Pearson ML, Kurup VP, Havens PL, Byrd RS, Setlock MA, et al: A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: Epidemiological features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 1994;94:53–61.
  19. Michael T, Niggemann B, Moers A, Seidel U, Wahn U, Scheffner D: Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996;26:934–939.

    External Resources

  20. Pittman T, Kiburz J, Gabriel K, Steinhardt G, Williams D, Slater J: Latex allergy in children with spina bifida. Pediatr Neurosurg 1995;22:96–100.
  21. Kaufman BA, Terbrock A, Winters N, Ito J, Klosterman A, Park TS: Disbanding a multidisciplinary clinic: Effects on the health care of myelomeningocele patients. Pediatr Neurosurg 1994;4:36–44.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50